FY20 SOW Detail Prescription Data Purchase revised.pdf

Statement of Work Purchase of Prescription Drug Shipments Data

Section 1 - Introduction/Background

BEA provides many economic measurements as part of the National Income and Product Accounts (NIP As). The NIPAs are used for a variety of purposes in setting national economic policy and in forecasting and interpreting macroeconomic activity. They include gross domestic product (GDP), which is considered the most useful summary measure of the nation's production. BEA, as the nation's accountant and as one of the world's leading statistical agencies, collects source data, conducts research and analysis, develops and implements estimation methodologies and disseminates statistics to the public. In this role, BEA collects source data from many specific sectors of the economy.

The contract will be defined as a Firm Fixed Price contract. The product must be provided on a monthly basis at a fixed rate for each year as described in Section 5. The Government will require no less than one year (or 12 months) of data.

Section 2 - Statement of Objectives

BEA is the nation's economic accountant, producing measures such as GDP, one of the most important statistical releases for its effect on financial markets. Personal consumption expenditures (PCE) is the major component of GDP on the product side of the accounts, comprising about 70% of

GDP.

BEA collects source data for specific sectors of the economy. PCE measures the goods and services purchased by the personal sector of the U.S. economy. The objective of this procurement is to obtain monthly data on retail sales of prescription drugs for the calculation of the PCE goods estimates.

Section 3 - Scope of Work

The procurement of detailed monthly prescription drug retail sales data is very important for calculating GDP estimates. The data must be available no later than 18 days after the reference month. The data must be provided monthly, in a continuous time series.

Section 4 – Deliverables

The Bureau of Economic Analysis will use these data to construct estimates of PCE goods. The following are data requirements, in Excel or compatible format:

1. Monthly data, all Products at a Total Market Level

2. Data must include the total retail prescription drug market broken down by channel and include

NRx Pharmacy Dollars, TRx Pharmacy Dollars, NRx Retail Dollars, TRx Retail Dollars,

3. Provide estimate of expected percent change within 18 days of the reference month.

4. The retail sales data for prescription drugs must include detail from the following groupings:

(Retail (including Sub-Channel) Mail Order, LTC data); (Rx Prescriptions, OTC Prescriptions, Unknown Prescriptions)

• Chain Stores

• Mail Service

• Independent

• Food Stores

• Long-term Care

Delivery Schedule: Monthly data will be delivered in a timely manner, lagging no more than 18 days after the reference month ends.

Section 5 – Period of Performance The Government anticipates a base year plus four (4) optional years as follows:

Base Period 7/1/2020 – 6/30/2021 Option Year 1 7/1/2021 – 6/30/2022 Option Year 2 7/1/2022 – 6/30/2023 Option Year 3 7/1/2023 – 6/30/2024 Option Year 4 7/1/2024 – 6/30/2025

BEA reserves the right not to execute the option years of the contract, if the products are not needed or if the Contractor fails to provide the data required within the specified time (see Section 4) or does not meet the performance standards for invoicing procedures, and/or correct billing procedures (see attached).